DrugDashboards
← Home
Manufacturing facility

Chartwell Pharmaceuticals Congers, LLC.

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
United States
Registered address
77 Brenner Drive, Congers, New York (NY) 10920, United States (USA)
Operations here
analysislabelmanufacturepackrelabelrepack
FDA identifiers
FEI 3008897678 · DUNS 118673447

Recent inspection flagged official action

FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 35 drugs, 3 already in shortage. A supply problem here can ripple to all of them.

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • OAIDrug Quality Assurance2025-11-18
  • VAIBioresearch Monitoring2024-04-08
  • VAIDrug Quality Assurance2023-05-24
  • VAIDrug Quality Assurance2018-09-26
  • VAIBioresearch Monitoring2016-11-01
  • NAIDrug Quality Assurance2014-06-23
  • VAIDrug Quality Assurance2012-09-19

Drugs this plant is listed as making

35 distinct drugs across 72 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.